FOR RESEARCH USE ONLY | Not for human consumption. Not evaluated by any regulatory body.
The Aevivo Journal

The newest breakthroughs. The wildest buzz. Our take.

The latest research from the field, the hype we're watching, and our five cents on what actually matters.

Supply Chain · 7 min read

What ends up in the bottle.

Channel 4 News exposed Synedica selling fake retatrutide pens as an Eli Lilly investigational product. Here is what the case, and independent testing, keeps revealing about the grey-market peptide trade.

24 April 2026Read →
How to Buy · 4 min read

How to read a Certificate of Analysis in under a minute.

The three things to check on every CoA, the four red flags most buyers miss, and a worked example using a real Epitalon release document.

23 April 2026Read →
Provenance · 6 min read

Inside a European peptide supply chain.

What actually happens when a peptide is made inside an EU GMP-certified facility, step by step. We describe our own supply chain because buyers should know.

23 April 2026Read →
Policy · 5 min read

What the FDA's peptide meeting actually changed.

The regulatory shift in plain language, who it actually affects, and three things buyers should do differently now. Most of the headlines got it wrong.

23 April 2026Read →

Want these in your inbox?

We send new pieces as they land. No filler, no unsubscribes needed - one article at a time.

Back to Aevivo